【24h】

Hereditary Determinants of Human Hypertension

机译:高血压的遗传决定因素

获取原文

摘要

Essential hypertension is characterized by chronically elevated blood pressure with no specific underlying medical cause. Data on family history of affected individuals coupled with disease concordance rate in twins has established that both genetic and environmental factors determine susceptibility to hypertension. The heritability of hypertension is often cited in the range of ≈30% to 60%, with multiple contributory genes; additionally, ethnic and genetic heterogeneity participate in variable clinical presentation and drug response in hypertension, rendering genetic study of this disease a challenging task. Human population and animal studies have implicated several important etiologic pathways contributing to the clinical presentation of essential hypertension that enable functional candidate gene association studies, in addition to more comprehensive genome wide linkage or association studies. Recent results also suggest a complex genetic architecture for hypertension and its associated risk traits, including evidence for pleiotropy (one gene→multiple traits), epistasis (gene-by-gene interaction), and on occasion molecular heterosis (a more extreme phenotype for heterozygotes than either homozygote class). Here we highlight recent findings on the genetics of hypertension that may lead to new approaches for investigating the pathogenesis, diagnosis, treatment, and prognosis of the disease.Although blood pressure displays substantial heritability, typically reported at ≈30% to 60%,1 hypertension is likely to be a heterogeneous phenotype (trait). Applying the concept of “intermediate phenotypes”2,3 might enhance risk assessment for the development of future hypertension and its consequences, thus enabling more timely diagnosis and management of even “prehypertensive” individuals. Such intermediate phenotypes may be influenced earlier and more proximately by the genome than are ultimate disease/clinical traits such as hypertension, and therefore may assist in discovery of hypertension-predisposition loci.2,3Intermediate traits in physical, physiological/hemodynamic,4 autonomic/sympathetic,5–8 metabolic,9 inflammatory,9 oxidative,5 endothelial,10,11 and renal12 pathways displayed significant heritability, typically exceeding that reported for blood …
机译:原发性高血压的特征是长期升高的血压,没有特定的潜在医学原因。有关受影响个体的家族史以及双胞胎疾病的符合率的数据已经确定,遗传因素和环境因素均决定了高血压的易感性。高血压的遗传力通常在约30%至60%的范围内,具有多个共同的基因。此外,种族和遗传异质性参与高血压的可变临床表现和药物反应,使对该疾病的遗传研究成为一项艰巨的任务。人口和动物研究牵涉到一些重要的病因学途径,这些疾病有助于原发性高血压的临床表现,除了更全面的全基因组联系或关联研究外,还可以进行功能性候选基因关联研究。最近的研究结果还表明,高血压及其相关危险性状的遗传结构复杂,包括多效性(一个基因→多个性状),上位性(基因之间的相互作用)和偶发的分子杂种优势(杂合子的更极端表型)的证据。比任何一个纯合子类)。在这里,我们重点介绍了有关高血压遗传学的最新发现,这些发现可能会导致研究该病的发病机制,诊断,治疗和预后的新方法。尽管血压具有显着的遗传力,通常报道为≈30%至60%,1可能是异质表型(性状)。应用“中间表型” 2,3的概念可能会增强对未来高血压及其后果的风险评估,从而甚至可以对“高血压”个体进行更及时的诊断和管理。这种中间表型可能比最终疾病/临床特征(如高血压)更早,更受基因组影响,因此可能有助于发现高血压易感基因位点[2,3]。物理,生理/血液动力学,植物学/交感,5-8代谢,9炎性,9氧化,5内皮,10、11和肾12通路显示出显着的遗传力,通常超过血液报道的遗传力……

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号